LYTIX BIOPHARMA ASLYTIX BIOPHARMA ASLYTIX BIOPHARMA AS

LYTIX BIOPHARMA AS

No trades
See on Supercharts

LYTIX fundamentals

LYTIX BIOPHARMA AS financial statements, including revenue, expenses, and profit

The total revenue of LYTIX for the last quarter is 377.00 k NOK, and it's 63.20% higher compared to the previous quarter. The net income of Q4 24 is -31.91 M NOK.

Q2 '20
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: NOK
Q2 '20
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth